经颈动脉与锁骨下/腋动脉入路TAVR比较
本研究基于STS/ACC TVT注册数据库,比较经颈动脉(TC)与经锁骨下/腋动脉(TAx)入路行SAPIEN 3 TAVR的结局。结论提示股动脉入路不可用时,TC可能安全或更优。
要点
- TC组手术时间、透视时间、对比剂用量及住院时间均更优。
核心结论
- TC TAVR与TAx相比死亡率相似,但卒中风险显著降低,股动脉入路禁忌时TC可能安全或更优。
研究设计与样本
- 回顾性队列研究,数据来自STS/ACC TVT注册数据库(2015年6月至2019年10月),纳入使用SAPIEN 3/SAPIEN 3 Ultra行TC或TAx TAVR的患者,经1:2倾向性匹配比较两组结局。
临床怎么用
- 股动脉入路不可行时,TC入路可作为TAVR的替代选择,尤其关注降低卒中风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Subclavian/axillary (TAx) access has become the most frequently used alternative access route for transcatheter aortic valve replacement (TAVR). Transcarotid (TC) TAVR has grown in popularity recently. Comparative data between these 2 contemporary access methods is lacking. METHODS: Data were extracted from The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (TVT) Registry™ (June 2015 to October 2019) for patients undergoing TAVR by TC or TAx access with the SAPIEN 3 and SAPIEN 3 Ultra (Edwards Lifesciences, Irvine, CA) transcatheter heart valves. Procedural, index hospitalization, and 30-day outcomes were analyzed for TC vs TAx groups after 1:2 propensity matching of patient baseline characteristics. RESULTS: The study included 3903 cases, of which 801 TC and 3102 TAx procedures were compared. After 1:2 propensity matching, TC TAVR was associated with similar 30-day mortality (4.3% vs 5.2%, P = .34) but a significantly lower risk of stroke (4.2% vs 7.4%; hazard ratio, 0.56; 95% confidence interval, 0.38-0.83; P = .003) compared with TAx access. Other outcomes that favored TC over TAx included shorter procedure time (117.0 vs 132.4 minutes; P < .001) and fluoroscopy time (16.6 vs 21.6 min; P < .001), lower contrast volume (78.5 vs 96.7 mL; P < .001), shorter length of stay in the intensive care unit (24.3 vs 25.0 hours; P = .02) and hospital (2.0 vs 3.0 days; P = .002), and more patients discharged to home (82.9% vs 74.6%; P < .001). CONCLUSIONS: TC TAVR is associated with similar mortality and a significant reduction in stroke compared with the TAx approach. If femoral access is precluded, TC may be a safe, or at times, preferred avenue of transcatheter valve delivery.
引用
- Kirker E, Korngold E, Hodson RW, et al. Transcarotid Versus Subclavian/Axillary Access for Transcatheter Aortic Valve Replacement With SAPIEN 3. Ann Thorac Surg. 2020. PMID: 32712098. doi:10.1016/j.athoracsur.2020.05.141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。